FibroBiologics Introduces Scientific Advisory Board

/PRNewswire/ -- FibroBiologics, a clinical-stage company developing fibroblast cell-based therapeutics for chronic diseases, today introduced its scientific...

Related Keywords

Houston ,Texas ,United States ,Lee Smith ,Neil Bhowmick ,Elizabeth Shpall ,S Thomas Carmichael ,Claudia Lucchinetti ,Sinai Cancer Institute ,Division Of Cancer Medicine ,Cancer Research Professor ,Sinai Medical Center ,Broad Stem Cell Research Center ,University Of Texas Md Anderson Cancer Center ,Department Of Neurology ,David Geffen School Of Medicine ,Mayo Clinic Alix School Of Medicine ,Translational Sciences ,Cancer Biology Program ,Department Of Stem Cell Transplantation ,Chief Scientific Officer ,Thomas Carmichael ,David Geffen School ,Broad Stem Cell Research ,Mayo Clinic ,Translational Science ,Marcia Applebaum Professor ,Mayo Clinic Alix School ,Multiple Sclerosis ,Cancer Center ,Lee Smith Chair ,Stem Cell Transplantation ,Cellular Therapy ,Cedars Sinai Cancer Institute ,Medicine Cedars Sinai Medical ,Fibrobiologics ,